Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLGN OTCMKTS:HYBT NASDAQ:POCI NYSE:RBOT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLGNCollPlant Biotechnologies$2.63+0.4%$2.38$1.31▼$5.00$33.45M1.6153,489 shs3,645 shsHYBTHeyu Biological Technology$0.08$0.13$0.00▼$3.40$8.52M-17.745,371 shs10 shsPOCIPrecision Optics$4.39-0.5%$4.72$3.47▼$6.59$33.65M0.3814,181 shs6,537 shsRBOTVicarious Surgical$5.85+0.5%$8.08$5.00▼$19.00$34.69M1.430,675 shs15,434 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLGNCollPlant Biotechnologies0.00%-6.70%+2.75%+58.79%-47.70%HYBTHeyu Biological Technology0.00%-1.90%-58.75%+27,400.00%-67.00%POCIPrecision Optics0.00%-1.34%-5.57%-3.71%-18.33%RBOTVicarious Surgical0.00%+3.49%-12.87%-27.69%+1.80%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLGNCollPlant Biotechnologies$2.63+0.4%$2.38$1.31▼$5.00$33.45M1.6153,489 shs3,645 shsHYBTHeyu Biological Technology$0.08$0.13$0.00▼$3.40$8.52M-17.745,371 shs10 shsPOCIPrecision Optics$4.39-0.5%$4.72$3.47▼$6.59$33.65M0.3814,181 shs6,537 shsRBOTVicarious Surgical$5.85+0.5%$8.08$5.00▼$19.00$34.69M1.430,675 shs15,434 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLGNCollPlant Biotechnologies0.00%-6.70%+2.75%+58.79%-47.70%HYBTHeyu Biological Technology0.00%-1.90%-58.75%+27,400.00%-67.00%POCIPrecision Optics0.00%-1.34%-5.57%-3.71%-18.33%RBOTVicarious Surgical0.00%+3.49%-12.87%-27.69%+1.80%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLGNCollPlant Biotechnologies 3.00Buy$11.50338.76% UpsideHYBTHeyu Biological Technology 0.00N/AN/AN/APOCIPrecision Optics 0.00N/AN/AN/ARBOTVicarious Surgical 2.00Hold$7.0020.07% UpsideCurrent Analyst Ratings BreakdownLatest HYBT, CLGN, RBOT, and POCI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/21/2025CLGNCollPlant BiotechnologiesHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$11.008/20/2025CLGNCollPlant BiotechnologiesD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$12.008/13/2025RBOTVicarious SurgicalPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$8.50 ➝ $7.00(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLGNCollPlant Biotechnologies$510K65.37N/AN/A$1.18 per share2.22HYBTHeyu Biological Technology$80K106.47N/AN/A$0.38 per share0.22POCIPrecision Optics$17.63M1.90N/AN/A$1.66 per share2.63RBOTVicarious SurgicalN/AN/AN/AN/A$7.89 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLGNCollPlant Biotechnologies-$16.61M-$1.13N/AN/AN/A-541.34%-94.08%-68.62%11/3/2025 (Estimated)HYBTHeyu Biological Technology-$270KN/A0.00∞N/A-453.55%-6.43%-4.43%N/APOCIPrecision Optics-$2.95M-$0.89N/A∞N/A-32.84%-54.03%-32.48%9/29/2025 (Estimated)RBOTVicarious Surgical-$63.22M-$10.09N/AN/AN/AN/A-148.14%-98.07%11/11/2025 (Estimated)Latest HYBT, CLGN, RBOT, and POCI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/20/2025Q2 2025CLGNCollPlant Biotechnologies$0.29-$0.28-$0.57-$0.28$8.91 million$0.18 million8/12/2025Q2 2025RBOTVicarious Surgical-$2.61-$2.23+$0.38-$2.23N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLGNCollPlant BiotechnologiesN/AN/AN/AN/AN/AHYBTHeyu Biological TechnologyN/AN/AN/AN/AN/APOCIPrecision OpticsN/AN/AN/AN/AN/ARBOTVicarious SurgicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLGNCollPlant BiotechnologiesN/A4.604.40HYBTHeyu Biological TechnologyN/A0.350.34POCIPrecision Optics0.111.991.26RBOTVicarious SurgicalN/A5.115.11Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLGNCollPlant Biotechnologies21.69%HYBTHeyu Biological TechnologyN/APOCIPrecision Optics13.71%RBOTVicarious Surgical47.27%Insider OwnershipCompanyInsider OwnershipCLGNCollPlant Biotechnologies9.60%HYBTHeyu Biological Technology89.24%POCIPrecision Optics12.99%RBOTVicarious Surgical11.99%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLGNCollPlant Biotechnologies7012.72 million11.50 millionOptionableHYBTHeyu Biological Technology6103.25 million11.11 millionNot OptionablePOCIPrecision Optics807.67 million6.42 millionNot OptionableRBOTVicarious Surgical2105.93 million5.22 millionNo DataHYBT, CLGN, RBOT, and POCI HeadlinesRecent News About These CompaniesVicarious Surgical (NYSE:RBOT) Stock Rating Upgraded by Wall Street ZenSeptember 13 at 2:40 AM | americanbankingnews.comVicarious Surgical: Revolutionizing Minimally Invasive Procedures with Advanced RoboticsSeptember 1, 2025 | techannouncer.comTVicarious Surgical to Participate in the H.C. Wainwright 27th Annual Global Investment ConferenceAugust 28, 2025 | tmcnet.comVicarious Surgical (NYSE:RBOT) Director Sells $18,445.10 in StockAugust 28, 2025 | insidertrades.comVicarious Surgical Faces Setback as Human Trials for Surgical Robot Are DelayedAugust 25, 2025 | aktiencheck.deADonald Tang Sells 2,059 Shares of Vicarious Surgical (NYSE:RBOT) StockAugust 22, 2025 | insidertrades.comRobotic surgery heats up with clearances and clinical trialsAugust 20, 2025 | crainsnewyork.comCVicarious Surgical (NYSE:RBOT) Given New $7.00 Price Target at Piper SandlerAugust 15, 2025 | marketbeat.comVicarious Surgical’s Earnings Call: Progress Amid ChallengesAugust 14, 2025 | msn.comVicarious Surgical delays robot clinical timelineAugust 14, 2025 | finance.yahoo.comVicarious Surgical’s new CEO pushes back robot development timelineAugust 14, 2025 | fiercebiotech.comFVicarious Surgical delays robot timelineAugust 14, 2025 | finance.yahoo.comVicarious Surgical pushes back surgical robot timeline againAugust 13, 2025 | massdevice.comVicarious Surgical Inc. (NYSE:RBOT) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | msn.comVicarious Surgical Reports Improved Q2 Financials and Leadership ChangeAugust 13, 2025 | msn.comVicarious Surgical Inc. (RBOT) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | seekingalpha.comVicarious Surgical anticipates FY25 cash burn of about $50MAugust 12, 2025 | msn.comVicarious Surgical reports Q2 EPS ($2.23), consensus ($2.50)August 12, 2025 | msn.comVicarious Surgical Reports Second Quarter 2025 Financial ResultsAugust 12, 2025 | businesswire.comVicarious Surgical names Stephen From as next CEOAugust 2, 2025 | medtechdive.comMVicarious Surgical Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, Appointed Chief Executive OfficerJuly 31, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHYBT, CLGN, RBOT, and POCI Company DescriptionsCollPlant Biotechnologies NASDAQ:CLGN$2.63 +0.01 (+0.38%) Closing price 03:57 PM EasternExtended Trading$2.62 0.00 (-0.19%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.Heyu Biological Technology OTCMKTS:HYBT$0.08 0.00 (0.00%) As of 09/12/2025Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation.Precision Optics NASDAQ:POCI$4.44 +0.03 (+0.68%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.Vicarious Surgical NYSE:RBOT$5.85 +0.03 (+0.52%) Closing price 03:59 PM EasternExtended Trading$5.97 +0.12 (+2.03%) As of 06:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Commercial Growth Story Is Just Getting Started The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Royal Caribbean's 33% Dividend Hike Signals Deeper Growth MarketBeat Week in Review – 09/08 - 09/12 Adobe’s Rebound Has Room to Run: 25% Upside by Year-End Wall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
